Xarelto (Rivaroxaban) Risk Minimisation Plan Evaluation

• Research type

  Research Study

• Full title

  Xarelto (Rivaroxaban) Risk Minimisation Plan Evaluation: Patient and Physician Knowledge of Key Safety Messages

• IRAS ID

  133925

• Contact name

  Terry McCormack

• Contact email

  tesmcc@aol.com

• Sponsor organisation

  Bayer Plc

• REC name

  East Midlands - Nottingham 2 Research Ethics Committee

• REC reference

  13/EM/0371

• Date of REC Opinion

  24 Sep 2013

• REC opinion

  Favourable Opinion